Merck (MRK)

• Market cap: $298B
• 1 day: 0.84%
• 5 days: 5%
• 1 month: 0.74%
• 3 months: 3.63%
• 6 months: 13.29%
• Year to date: 13.29%
• 1 year: 50.15%
• 5 years: 57.94%
• 10 years: 126.18%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000